Current Neuro-Oncology

Volume 27 Number 36
31 December 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 36, 31 December

Chen CG, Rameh V, Rosenberg T, Yeo KK, Chi S, Wright KD, Baird LC, Filbin MG, Fehnel KP, Abdullaev Z, Aldape KD, Lidov HG, Alexandrescu S.
H3K27M- and BRAF V600E-Altered gliomas and glioneuronal tumors-clinico-pathologic and radiologic perspective in a cohort treated with targeted therapy.
Neurooncol Adv. 2025 Sep 8;7(1):vdaf197. doi: 10.1093/noajnl/vdaf197. PMID: 41473746. Observational study. ˍ

Mikic N, Lukacova S, Skjøth-Rasmussen J, Poulsen FR, Hauerberg J, Laursen RJ, Ettrup KS, Møller S, Haslund CA, Dahlrot RH, Cortnum SOS, Sindby AK, Von Oettingen G, Valentin JB, Solheim O, Solheim TS, Sørensen JCH, Wong ET, Korshøj AR.
Dose-enhanced versus standard TTFields for first recurrence of glioblastoma: A randomized phase 2 clinical trial.
Neurooncol Adv. 2025 Nov 20;7(1):vdaf245. doi: 10.1093/noajnl/vdaf245. PMID: 41473750. Interventional study. ˍ

Ruggiero A, Talloa D, Romano A, Attinà G, Mastrangelo S, Maurizi P, Verdolotti T, Tamburrini G, Chiesa S, di Bonaventura R, Mattogno PP, Olivi A, Albanese A.
Outcomes and Toxicity of Adult Medulloblastoma Treated with Pediatric Multimodal Protocols: A Single-Institution Experience.
Oncol Res. 2025 Nov 27;33(12):3855-3867. doi: 10.32604/or.2025.067948. PMID: 41425728. Observational study. ˍ